SBIR/STTR Research Award
Wavelet-Based AROS Compresion of Cytogenetic Images
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Advanced Digital Imaging Research, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): The goal of this project is to develop
innovative image compression techniques to make the digital storage, archiving,
and communication of cytogenetics images much more efficient and faster,
thereby significantly reducing the storage and transfer costs of digital
cytogenetics imaging instruments in clinical diagnosis and in genetics and
cancer research. Our approach takes advantage that, for mostcytogenetics
images, the regions of interest to cytogeneticists are well determined and
segmented before storage. The recently developed wavelet-based arbitrary region
of support (AROS) coding approach offers an effective means of region-segmented
image compression, and promises significant improvement over currently
available techniques.
In Phase 1 we will study the feasibility of wavelet-based AROS compression of
monochrome cytogenetics images. We will evaluate in terms of compression
ratios, compression gains, coding speed, and error resilience on test images
including 0-banding chromosome spreads and karyotypes, FISH and cDNA images. If
the proposed approach can effect a significant improvement, in Phase 2 the
technique will be extended to and tested on multispectral FISH/M-FISH and cDNA
microarray images. When fully developed, the new technology will be made
available to Applied Imaging (AIC) for integration into the PowerGene
cytogenetics automation products. This will result in far more cost-effective
commercial instruments.
PROPOSED COMMERCIAL APPLICATION:
As soon as the new techniques are developed and qualified for routine application, they
will be made available to AIC for incorporation into the PowerGene product line of
cytogenetics automation equipment, both in new systems sold and as an upgrade to
existing systems already in use in cytogenetics labs, thus commercializing the technology
quickly.
Technology keywords
Not reported